ARCHIVES

Rauscher Responds To Criticism

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16

August 22, 1975

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

Executive Committee, Board of Scientific Advisors concur.

January 2, 2004

Some Cancer Control Projects On Thin Ice As Board Eyes Funds For Others

January 29, 1982